4.7 Article

Inhibition of RhoA GTPase activity enhances hematopoietic stem and progenitor cell proliferation and engraftment

Journal

BLOOD
Volume 108, Issue 6, Pages 2087-2094

Publisher

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2006-02-001560

Keywords

-

Categories

Funding

  1. NHLBI NIH HHS [2P02 HL 69974, P01 HL069974] Funding Source: Medline
  2. NIDDK NIH HHS [R01 DK062757, 1R01 DK 062757] Funding Source: Medline

Ask authors/readers for more resources

Ras-related Rho GTPases regulate actin cytoskeletal organization, adhesion, gene transcription, and cell-cycle progression. The Rac subfamily of Rho GTIPases and Cdc42 has been shown to play essential roles in hernatopoletic stem cell (HSC) engraftment and mobilization. Here, we study the role of RhoA, a related Rho GTPase, in HSC functions. Using retrovirus-mediated gene transfer of a dominant-negative (DN) mutant of RhoA (RhoAN19), we demonstrate that down-regulation of RhoA activity resulted in increased HSC engraftment and self-renewal as measured by competitive repopulation and serial transplantation assays. However, overexpression of RhoAN119 resulted in decreased migration toward SDF-1 alpha and alpha(4)beta(1)- and alpha(5)beta(2)-integrin-mediated adhesion of hematopoietic progenitor cells in vitro. Low RhoA activity was associated with higher proliferation rate of hematopoietic progenitor cells and increased cells in active phases of cell cycle, most likely via decreasing p21Cip/Waf expression and increasing cyclin D1 levels. Thus, reducing RhoA activity by optimizing the balance between adhesion/migration and proliferation/self-renewal results in a net increase in HSC engraftment. This mechanism could provide a novel therapeutic target to enhance HSC therapies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available